Prof Jutta Heim – Venture Partner
Prof. Jutta Heim joined Aravis as a Venture Partner in 2014.
In addition to holding board positions at Evolva SA and at Nuevolution SA. From 2009 to 2013 she has been the Chief Scientific Officer of Evolva SA with responsibility for all Synthetic Biology and metabolic engineering work for the production of new or known natural products. Until 2009, Dr. Heim was Chief Scientific Officer of Basilea Pharmaceutica AG, a Swiss biopharmaceutical company, where she was in charge of all anti-infective, dermatology and oncology discovery activities.
Prior to joining Basilea Pharmaceutica, Dr. Heim worked for 22 years in Switzerland and the United States for Ciba-Geigy/Novartis, where she was involved in the successful development and launch of biopharmaceuticalanti-thrombotic and fibrinolytic products, initiated a molecular genetics department in oncology and became Novartis' Senior Scientific Expert in Molecular Biology and a member of the Research Management Board.